|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.77 USD | +4.55% |
|
-14.44% | -80.36% |
| Mar. 29 | Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 28 | Transcript : Accelerate Diagnostics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Accelerate Diagnostics, Inc. provided earnings guidance for the year 2022. For the quarter, the company expected to come in just below the low end of revenue guidance of $13 million to $14 million for the year.
| 1st Jan change | Capi. | |
|---|---|---|
| -80.36% | 15.96M | |
| +2.02% | 209B | |
| +2.17% | 177B | |
| +10.45% | 133B | |
| +16.62% | 99.89B | |
| -2.70% | 61.83B | |
| +13.38% | 52.51B | |
| -6.33% | 45.54B | |
| -4.74% | 39.43B | |
| +9.89% | 38.87B |
ACCELERATE DIAGNOSTICS, INC. 
